IceCure files for Canadian regulatory clearance for ProSense

2019 02 12 23 11 2325 Canada Flag 400

IceCure Medical has filed paperwork with Health Canada requesting clearance for market of its ProSense liquid nitrogen-based cryoablation system.

ProSense is used to ablate both benign and malignant breast, lung, liver, and musculoskeletal, lung, and renal lesions, as well as for palliative treatment. It currently has marketing clearance in the U.S. and Europe.

Page 1 of 57
Next Page